News Focus
News Focus
icon url

shabby47

12/10/14 10:33 AM

#9008 RE: ttboy #9007

This is correct. And their most important application right now (n-assay) which has yet to be allowed will hopefully have 18+ years on it once it is issued.

Most of their parents have well over 10 years left which is plenty of time. They just need to make that time count
icon url

capitalismforever

12/10/14 10:41 AM

#9009 RE: ttboy #9007

"The EU patient, for example, expires in 14 years. You believe the wheels won't be spinning by then? I disagree, the wheels have begun. Time will tell. If anyone disagrees they can certainly sell their position."

Good point, yes it's true EU patents expire quicker than U.S. Patents. Let's go back in a time machine to 8 years ago. Ask that question again and ponder the thought for a minute. $18,550 in revenue is not the definition of "the wheels have begun". It's the definition of "scrounging for enough change to purchase a cheeseburger".
icon url

shabby47

12/10/14 10:50 AM

#9011 RE: ttboy #9007

Also, with regard to the n-assay patent, this is from another board:

Update on patent application 13/350127.

As I previously noted here just a few days ago, the application above had received a non-final rejection with most of the claims allowed and a few dependent claims rejected under 35 usc 112. For those not familiar with the process, those rejections are made with regard to legal issues and essentially formatting rather than the actual invention.

As expected, they have filed an amendment to clear that up which can now be seen in uspto pair.

What this means is that assuming the amendments are ok (they simply deleted the subject matter in question, so they should be) we should be able to expect an allowance shortly.

This is the bnp patent that uses aptamers to cut down on detection time I believe. Very important to the company in my opinion.